Moilanen, Anu-Maarit <br/><br/>
Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies.  [electronic resource] 

 -  Scientific reports  Jul 2015 
 - 12007 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep12007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Receptor Antagonists--pharmacology<br/>Androgens--physiology<br/>Animals<br/>Antineoplastic Agents--pharmacokinetics<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>HEK293 Cells<br/>Humans<br/>Male<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Prostatic Neoplasms--drug therapy<br/>Pyrazoles--pharmacokinetics<br/>Receptors, Androgen--metabolism<br/>Signal Transduction<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays